Clinical Significance of Mir-138 Expression in Gastric Mucosal Carcinogenesis

LI Xue-cheng,WANG Zong-hua,HANG Guang-ping,LIU Zhi-peng,WANG Jun,ZOU Li-quan,XIONG Xiao-feng,CHEN Ling
DOI: https://doi.org/10.13602/j.cnki.jcls.2011.07.041
2011-01-01
Abstract:Objective To investigate the expression of human telomerase reverse transcriptase(hTERT),and hTERT-regulating miR-138 in normal mucosa(NM),intestinal metaplasia(IM),dysplasia(DYS),early gastric cancer(EGC)and advanced gastric cancer(AGC) as well as its clinical significance.Methods Ninety six patients were included in this study.The expression levels of hTERT protein was detected by immunohistochemistry and miR-138 was detected by real-time PCR.Results In NM,IM,DYS,EGC and AGC groups,the positive expression rate of hTERT protein was 0.0%,26.1%,33.3%,75.0% and 77.4% respectively,and the relative quantity of miR-138 was 2.93±1.24,2.12±0.98,1.90±0.58,1.27±0.89 and 1.68±1.02 respectively.Clinicopathological analysis revealed that miR-138 expression was significantly lower in poorly or undifferentiated gastric cancer than that in highly or moderate differentiated group(83.3% vs 36.5%,P0.01),but there were no statistically significant differences for sex,age,lymph node metastasis and TNM staging.Conclusion The miR-138 down-regulation occurred early during the gastric carcinogenesis.It should be suggested that miR-138 may act as a promising early diagnostic biomarker or therapeutic target for gastric cancer.
What problem does this paper attempt to address?